SCHEMBL5494040

SCHEMBL5494040

CCN(c1ccccc1)c1ncnc2ccc(NC(=O)CCNC(=O)CS(C)(=O)=O)cc12

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EGFR P00533 7/20 0.44
CSF1R P07333 2/20 0.44
SMN1; SMN2 Q16637 1/20 0.42
MAP4K4 O95819 4/20 0.41
ALDH1A1 P00352 3/20 0.40
MAPK1 P28482 2/20 0.40
KMT2A Q03164 1/20 0.39
LMNA P02545 2/20 0.38
USP2 O75604 1/20 0.38
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
CLK4 Q9HAZ1 1/20 0.38
MCHR1 Q99705 1/20 0.37
PRNP P04156 1/20 0.37
GAA P10253 1/20 0.37
MAPT P10636 1/20 0.37
FYN P06241 1/20 0.37
SRC P12931 1/20 0.37
POLB P06746 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5496061 0.89 EGFR (0.48) EGFRCSF1RSMN1; SMN2ALDH1A1MAPK1
SCHEMBL5496208 0.86 FYN (0.48) EGFRCSF1RFYNSRC
SCHEMBL5499105 0.84 EGFR (0.51) EGFRCSF1RSMN1; SMN2MAP4K4ALDH1A1
SCHEMBL2248251 0.79 FYN (0.58) EGFRALDH1A1MAPK1KMT2ALMNA
SCHEMBL5494041 0.78 SRC (0.61) EGFRMAPK1LMNAUSP2CYP1A2
SCHEMBL2249929 0.77 EGFR (0.51) EGFRLMNA
SCHEMBL2251058 0.76 AURKB (0.53) EGFRKMT2ALMNAUSP2CYP1A2
SCHEMBL2248288 0.71 EGFR (0.65) EGFR
SCHEMBL2248227 0.70 ERBB2 (0.60) EGFRSMN1; SMN2ALDH1A1MAPK1KMT2A
SCHEMBL4741965 0.70 EGFR (0.63) EGFRCSF1RSMN1; SMN2ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1844022-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF Hanmi Pharm. Co., Ltd. (KR) 2007-10-17 EP disclosed
WO-2006071017-A1 QUINAZOLINE DERIVATIVES FOR INHIBITING CANCER CELL GROWTH AND METHOD FOR THE PREPARATION THEREOF HANMI PHARM. CO., LTD. (KR) 2006-07-06 WO disclosed